OUR MISSION
To build and evolve the European cannabis space while fervently committing to creating high quality products, innovating and improving lives.
Production
100% Swiss Made
HolyWorld SA. is a leading producer of cannabis derived products in Switzerland and Europe. We are actively involved in helping modernise and innovate in the global cannabis industry.
Founded in January 2018 by dynamic entrepreneurs, Holyworld is now a subsidiary of one of the world’s biggest Cannabis conglomerates, MPXI Corporation. We are in search of excellence and opportunities made possible by an emerging global industry. Consumer experience is at heart of everything we do to ensure MPXI brands reflect the tastes and preferences of current enthusiasts and future customers.
All our flowers are certified, 100% Swiss Made, tobacco and additive free. Our plants are grown on the shores of Lake Geneva with facilities located between the lake the Alps
Production
Bio-Organic Certified
For more than 3 years, Our bio-organic certification guaranties you that our processes of cultivation, harvesting, drying, manicure and curing that best respect the integrity and intrinsic qualities of the plants and that make our products a reference of superior quality unanimously recognized on the market.
All our Swiss-premium quality products are grown, manufactured, and designed to exceed customer satisfaction and serve as the forerunners of the industry.
Real time MPXI stock ticker
Award winning
HolyWorld SA is an international subsidiary of the award-winning cannabis pioneers MPXI. Since 2015, MPXI have been developing leading cannabis operations and innovating award-winning products across both consumer and medical industries in North America. Our managers at MPXI have grown MPX bioceutical from a single Licensed Producer in Canada into one of the largest vertically-integrated, multi-state operators in the US and the world.
MPX bioceutical was acquired in 2018 for $835 millions. This acquisition gave our managers an opportunity to create a separate global brand which became MPXI International Corporation.
MPXI Corp. believes that building long-term international connections is the key to drive market shares. It is in our DNA to value sustainability, innovation and quality.
Founded MPX Bioceutical in
2015
Retail locations opened
12
Scaled our annual production to
8850kg
Revenue Run-Rate
$100milion+
Debt and Equity Financing
$105million+
Sold in 2018 for
$835million
Founded MPX Bioceutical in
2015
States expanded into
5
Retail locations opened
12
Premium SKUs
145+
Scaled our annual production to
8850kg
Debt and Equity Financing
$105million+
Melting Point Extracts (MPX) is our award-winning cannabis brand, devoted to providing the cleanest and most effective products possible. MPX specializes in Hydrocarbon, CO2, and solvent-free extractions to provide a diverse line of high-quality products including live resin concentrates, wax, sauce, and diamonds.
Meet
OUR TEAM
Holyworld SA
Alastair Crawford
Chief Executive
Louis-Philippe Escudié
Head of Business Development
Harnoor Grewall
Head of Business Strategy
Nicholas Varone
VP Extraction
Cédric Heeb
MPXI Labs
Board of Directors MPXI Corporation
Scott Boyes
Jeremy Budd
Alastair Crawford
Robert Petch
Randall Stafford
Management MPXI
Scott Boyes
CEO and Chairman
Jeremy Budd
Executive Vice President and General Counsel
Jonathan Chu
Vice President and CFO
Michael Arnkvahn
Chief Operating Officer
Karl Bartolo
General Manager – Malta
MPXI Board of Advisors
Dr. Charles Akle
Saul Greenblatt
Jean-Marc Levy
Discover
OUR ACTIVITIES
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
